Ortho Novum 7/7/7 generics
Executive Summary
Barr's branded generic Nortrel 7/7/7 launches Jan. 2 with AWP of $193.28 for six dials, a 10% discount to Ortho-McNeil's oral contraceptive Ortho Novum 7/7/7 (norethindrone/ethinyl estradiol), according to Price Alert. Watson's authorized generic, Necon 7/7/7, has an AWP 10 cents below Barr's. Watson launched simultaneously with Barr under an agreement with Ortho (1"The Pink Sheet" Nov. 4, 2002, p. 20)...
You may also be interested in...
Watson “Authorized” Generic Tri-Cyclen Will Share Market With Barr
Watson will launch an "authorized" generic version of Ortho-McNeil'soral contraceptive Ortho Tri-Cyclen when Barr enters the market with its generic under an agreement between Watson and Ortho announced Oct. 28
Roche/Genentech Keeps Commitment To External Cancer Innovation
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
US FDA Eases Changes For Certain Sterile Injectable Container Closure Materials
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: